deltatrials
Completed PHASE3 INTERVENTIONAL 2-arm NCT04182373

KW-3357 Study in Patients With Early Onset Severe Preeclampsia

A Phase 3, Randomized, Placebo-controlled, Double Blind Study of KW-3357 in Patients With Early Onset Severe Preeclampsia

Sponsor: Japan Blood Products Organization

Conditions Preeclampsia
Interventions Antithrombin gamma physiological saline
Updated 10 times since 2020 Last updated: Nov 13, 2023 Started: Nov 19, 2019 Primary completion: May 17, 2023 Completion: Jun 16, 2023
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Preeclampsia, this trial is completed. The trial is conducted by Japan Blood Products Organization and has accumulated 10 data snapshots since 2019. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Jan 2020 – ~Nov 2020 · 10 months · monthly snapshotRecruiting~Nov 2020 – ~Jan 2021 · 2 months · monthly snapshot~Jan 2021 – ~Apr 2022 · 15 months · monthly snapshotRecruiting~Apr 2022 – ~Dec 2022 · 8 months · monthly snapshotRecruiting~Dec 2022 – ~Aug 2023 · 8 months · monthly snapshotRecruiting~Aug 2023 – ~Dec 2023 · 4 months · monthly snapshot~Dec 2023 – ~Jul 2024 · 7 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotCompleted~Sep 2025 – present · 12 months · monthly snapshotCompleted

Change History

10 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed PHASE3

  2. Sep 2024 — Sep 2025 [monthly]

    Completed PHASE3

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE3

  4. Dec 2023 — Jul 2024 [monthly]

    Completed PHASE3

  5. Aug 2023 — Dec 2023 [monthly]

    Completed PHASE3

    Status: Recruiting → Completed

▶ Show 5 earlier versions

  1. Dec 2022 — Aug 2023 [monthly]

    Recruiting PHASE3

  2. Apr 2022 — Dec 2022 [monthly]

    Recruiting PHASE3

  3. Jan 2021 — Apr 2022 [monthly]

    Recruiting PHASE3

  4. Nov 2020 — Jan 2021 [monthly]

    Recruiting PHASE3

  5. Jan 2020 — Nov 2020 [monthly]

    Recruiting PHASE3

    First recorded

Nov 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Japan Blood Products Organization
  • Kyowa Kirin Co., Ltd.
Data source: Kyowa Kirin Co., Ltd.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Abeno-ku, Japan , Aomori, Japan , Bunkyo, Japan , Bunkyo-ku, Japan , Fuchū, Japan , Fukuoka, Japan , Hakodate, Japan , Hamamatsu, Japan , Himeji, Japan , Hirakata, Japan and 49 more locations